Jack Chia Industries (Thailand) Public Company Limited

Jack Chia Industries (Thailand) Public Company Limited

JCT.BK
Jack Chia Industries (Thailand) Public Company LimitedTH flagStock Exchange of Thailand
82.75
THB
- -
- -
1.12BMarket Cap
Jack Chia Industries (Thailand) Public Company Limited
JCT.BK
(Stock Exchange of Thailand)

Recent

price

82.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
42.08
44.07
53.97
55.16
61.64
61.5
61.07
60.78
60.88
65.55
58.62
51.76
55.46
59.77
61.14
64.61
65.59
Revenue per Share
5.03
6.18
6.96
7.01
9.1
7.21
5.57
6.57
6.64
6.72
4.99
4.85
6.55
7.05
7.31
8.59
9.1
Basic EPS, GAAP
1.27
0.79
1.03
4.85
7.81
6.02
7.43
6.8
5.79
5.12
8.16
7.12
2.57
3.81
5.63
8.92
5.76
Free Cash Flow per Basic Share
4.14
3.41
1.8
3.9
4.09
4.87
3.9
3.89
3.99
4.07
4.09
3.43
3.41
3.89
4.12
6.5
6.5
Dividend per Share
21.87
23.08
28.19
36.08
41.75
43.96
45.25
47.76
50.3
52.39
52.9
54.31
57.72
60.77
63.84
67.72
70.8
Book Value per Share
44.55
51.35
56.67
59.5
65.12
66.35
78.84
81.93
84.94
87.28
87.89
92.73
96.3
99.51
102.11
105.4
108.51
Tangible Book Value per Share
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
Basic Weighted Avg Shares
568
595
729
745
832
830
824
820
822
885
791
699
749
807
825
872
885
Sales/Revenue/Turnover
15.48
19.72
16.58
15.93
15.69
13.88
9.32
11.07
12.17
12.32
8.49
9.44
13.33
12.99
12.39
13.93
13.8
Operating Margin (%)
8
9
10
16
19
20
24
26
25
24
25
22
20
19
17
17
17
Depreciation Expense
68
83
94
95
123
97
75
89
90
91
67
66
88
95
99
116
123
Net Income, GAAP
26.81
28.95
22.24
20.08
17.69
15.2
14.84
11.41
14.81
16.1
17.34
17.67
19.5
18.27
18.38
11.83
12.09
Effective Tax Rate (%)
11.96
14.01
12.89
12.71
14.77
11.73
9.11
10.82
10.91
10.25
8.51
9.37
11.81
11.79
11.96
13.3
13.87
Profit Margin (%)
357
349
385
404
476
490
509
542
577
622
637
669
689
630
781
863
892
Working Capital
- -
- -
- -
6
5
4
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
625
713
782
823
899
929
1,093
1,128
1,163
1,192
1,196
1,259
1,305
1,347
1,388
1,440
1,482
Total Equity
10.11
12.2
12.34
11.59
12.24
10.54
6.41
7.2
7.41
7.74
4.63
4.41
6.24
6.44
6.08
7.56
7.34
Return on Invested Capital (%)
23.43
27.48
27.14
21.68
23.14
16.71
12.42
14.16
13.57
13.13
9.51
9.09
11.73
11.95
11.8
13.14
13.33
Return on Capital (%)
23.43
27.48
27.14
21.81
23.39
16.83
12.48
14.14
13.55
13.09
9.47
9.05
11.69
11.89
11.73
13.06
13.26
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
1,073
1,134
1,077

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
919
955
980
Cash, Cash Equivalents & STI
442
460
481
Accounts Receivable, Net
209
221
219
Inventories
248
251
254
Total Current Liabilities
84
93
88
Payables & Accruals
76
75
73
ST Debt
- -
- -
- -
Deferred Revenue
6
13
11

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.57%
3.79%
3.77%
Free Cash Flow
12.57%
15.54%
58.49%
Net Income, GAAP
3.28%
12.23%
17.55%
Sales/Revenue/Turnover
0.73%
2.24%
5.68%
Total Cash Common Dividend
4.61%
12.24%
57.91%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
216
197
195
217
825
2025
219
213
224
217
872
2026
232
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.42
2.06
0.65
- -
7.31
2025
2.57
2.29
2.13
- -
8.59
2026
3.08
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
4.1
0.02
- -
4.12
2025
- -
6.42
0.08
- -
6.5
2026
- -
- -
- -
- -
- -
Business
Jack Chia Industries (Thailand) Public Company Limited engages in the manufacture and distribution of pharmaceutical and consumer products. The company operates primarily through two segments: pharmaceutical products and other consumer products. Its core product portfolio includes medical supplies such as bandages, elastic fabric adhesive dressings, and kinesiology tapes under the Tigerplast, Tensoplast, Kangaroo, Tabu, Thermaplast, Jason, Ronson, and Golden Lion brands. The company also produces toiletries and cosmetic products, including colognes, perfumes, soaps, shower creams, powders, and candies. Jack Chia serves markets primarily in Thailand, with its headquarters located in Bangkok, and it has subsidiaries including Pharmacare Limited and JCT New Frontiers Holdings Limited. Founded in 1966, the company maintains a significant presence in the Thai pharmaceutical and personal care sectors. In the past 1-2 years, Jack Chia Industries has focused on operational improvements and maintaining steady growth amid competitive challenges. The company has reported consistent earnings growth and stable margins while managing low long-term debt levels and maintaining efficient capital expenditures. Although there are no publicly disclosed major acquisitions or strategic alliances recently, the company continues to innovate within its product lines, enhancing its market share in both pharmaceutical and personal care segments. Jack Chia leverages established brand equity in its product categories, supported by ongoing investment in product quality and market expansion initiatives to preserve its competitive positioning in Thailand's pharmaceutical and toiletries markets. Jack Chia Industries targets a broad range of customers including healthcare providers, retailers, and consumers, offering products that span medical supplies, personal care, and confectionery. The company's notable branded products under Tigerplast encompass various support and dressing products for medical use, while the Tabu brand offers a range of toiletries and cosmetics. The continued focus on product development and customer base expansion reflects Jack Chia's strategic intent to sustain growth through brand diversification and enhanced product innovation. The company’s robust distribution network within Thailand supports its market penetration and accessibility to end-users. Overall, Jack Chia Industries remains a longstanding player specializing in pharmaceutical and consumer healthcare products in Thailand, leveraging a diversified product portfolio with stable financial fundamentals and incremental innovation efforts within its established markets to support sustained growth and operational efficiency. This description incorporates the most current available information on Jack Chia Industries (Thailand) Public Company Limited’s products, operations, market segments, and recent business performance trends.